c-MET inhibitors in the treatment of lung cancer
For intensive initial treatments, some protocols recommend 500-1,000 mg daily for four consecutive days, followed by a transition to twice-weekly injections for one month
These are less frequent but must be ruled out if symptoms persist or if risk factors exist
For those who prefer alternatives to injections, oral drops may be available as part of select weight loss programs
As demonstrated in the extant literature, METTL3 in CAFs-derived exosomes has been shown to promote proliferation, invasion, and glutamine metabolism in non-small cell lung cancer (NSCLC) cells by inducing m6A modification of SLC7A5 and stabilising its expression [133]
PMC Copper Shuttle: Safely escorts bio-available copper into cells, a co-factor for collagen cross-linking enzymes like lysyl oxidase